Table 1.
Variable | circMED27 |
p value | |
---|---|---|---|
Low (n = 75) | High (n = 75) | ||
Age (years) | |||
≤50 | 43 | 49 | 0.402 |
>50 | 32 | 26 | |
Sex | |||
Female | 23 | 31 | 0.234 |
Male | 52 | 44 | |
HBs Ag | |||
Negative | 4 | 6 | 0.745 |
Positive | 71 | 69 | |
HCV Ab | |||
Negative | 68 | 70 | 0.765 |
Positive | 7 | 5 | |
Liver cirrhosis | |||
Yes | 47 | 41 | 0.407 |
No | 28 | 34 | |
Serum AFP, ng/mL | |||
≤20 | 52 | 34 | 0.005 |
>20 | 23 | 41 | |
Serum ALT, U/L | |||
≤75 | 34 | 37 | 0.744 |
>75 | 41 | 38 | |
Tumor size (diameter, cm) | |||
≤5 | 47 | 30 | 0.009 |
>5 | 28 | 45 | |
Encapsulation invasion | |||
Absent | 45 | 39 | 0.411 |
Present | 30 | 36 | |
Vascular invasion | |||
No | 32 | 24 | 0.237 |
Yes | 43 | 51 | |
Tumor number | |||
Single | 31 | 27 | 0.615 |
Multiple | 44 | 48 | |
TNM stages | |||
I/II | 42 | 27 | 0.021 |
III/IV | 33 | 48 |
HBs Ag, hepatitis B surface antigen; HCV Ab, hepatitis C virus antibody; AFP, alpha-fetoprotein; ALT, alanine transaminase.